Ayurveda medicine for Ahiputana

Clinical study on the effect of Daruharidra Malahara in Ahiputana (Napkin dermatitis) - AY-AP

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032969

Enrollment

Registered

2021-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

Intervention1: Daruharidra malahara: sufficient quantity thrice daily for 10 days (external application) Control Intervention1: NIL: NA

Eligibility

Inclusion criteria

Inclusion criteria: 1. Infants diagnosed as the case of Ahiputana / Napkin dermatitis with the presenting symptoms. 2. Infants in between the age group after birth till 1 years irrespective of gender, religion, Socio economic status and food habits. 3. H/o of symptoms of Ahiputana /Napkin dermatitis not more than 10 days.

Exclusion criteria

Exclusion criteria: 1. Infants suffering from any other systemic disorders e.g. acute gastro enteritis with dehydration, Lactose intolerance, Secondary Infection etc. 2. Infants who have other generalized skin infections other than Ahiputana

Design outcomes

Primary

Measure	Time frame
Reduction in dermatitis in perineal and perianal areasTimepoint: 10 days	—

Secondary

Measure	Time frame
Patient well beingTimepoint: 10 days	—

Countries

India

Contacts

Public ContactDr Nupur Verma

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

rao.shaila@gmail.com9448816433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026